Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL.
Infection
; 45(4): 521-528, 2017 Aug.
Article
in En
| MEDLINE
| ID: mdl-28477212
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
HIV Infections
/
Ritonavir
/
Anti-HIV Agents
/
Viral Load
/
Darunavir
/
Raltegravir Potassium
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Infection
Year:
2017
Document type:
Article